SK bioscience Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	512,279	127,026	225,287	98,028
Short-Term Investments	136,430	275,300	5,300	-0
Trading Asset Securities	691,168	871,816	1,250,218	1,547,635
Cash & Short-Term Investments	1,339,877	1,274,141	1,480,806	1,645,663
Cash Growth	9.36%	-13.96%	-10.02%	-
Accounts Receivable	40,056	12,928	39,585	38,006
Other Receivables	11,070	9,414	50,076	10,129
Receivables	51,126	22,342	89,661	48,135
Inventory	106,607	80,649	187,406	135,046
Prepaid Expenses	1,349	1,613	1,649	1,407
Other Current Assets	3,955	4,224	24,173	7,554
Total Current Assets	1,502,914	1,382,969	1,783,694	1,837,804
Property, Plant & Equipment	415,690	315,923	293,057	220,983
Long-Term Investments	22,337	42,729	1,500	21,610
Other Intangible Assets	18,732	14,178	6,299	3,973
Long-Term Deferred Tax Assets	62,494	59,219	21,370	10,242
Long-Term Deferred Charges	9,967	8,281	11,882	13,088
Other Long-Term Assets	15,512	29,140	24,129	2,422
Total Assets	2,047,646	1,852,439	2,141,931	2,110,123
Accounts Payable	12,960	3,370	11,053	63,812
Accrued Expenses	10,878	19,716	30,242	26,322
Short-Term Debt	-	-	45,550	11,671
Current Portion of Long-Term Debt	-	-	38,008	47,978
Current Portion of Leases	6,074	8,137	12,235	2,309
Current Income Taxes Payable	-	-	20,216	101,486
Other Current Liabilities	98,610	104,397	222,733	206,374
Total Current Liabilities	128,523	135,620	380,037	459,952
Long-Term Debt	188,215	-	-	35,503
Long-Term Leases	10,802	12,436	17,543	8,775
Other Long-Term Liabilities	664.31	527.84	2,649	335.24
Total Liabilities	328,204	148,584	400,229	508,811
Common Stock	38,414	38,414	38,392	38,250
Additional Paid-In Capital	1,160,456	1,160,456	1,160,008	1,157,064
Retained Earnings	501,976	549,421	533,378	405,305
Comprehensive Income & Other	18,596	-44,435	9,924	692.92
Shareholders' Equity	1,719,442	1,703,855	1,741,702	1,601,312
Total Liabilities & Equity	2,047,646	1,852,439	2,141,931	2,110,123
Total Debt	205,092	20,574	113,336	106,236
Net Cash (Debt)	1,134,786	1,253,568	1,367,469	1,539,428
Net Cash Growth	-5.57%	-8.33%	-11.17%	-
Net Cash Per Share	14772.30	16277.20	17754.39	20850.38
Filing Date Shares Outstanding	76.83	76.83	76.78	76.5
Total Common Shares Outstanding	76.83	76.83	76.78	76.5
Working Capital	1,374,392	1,247,350	1,403,657	1,377,852
Book Value Per Share	22380.48	22177.60	22683.12	20932.18
Tangible Book Value	1,700,710	1,689,678	1,735,403	1,597,339
Tangible Book Value Per Share	22136.66	21993.06	22601.09	20880.24
Land	45,280	45,280	45,270	9,949
Buildings	121,640	124,315	127,741	119,990
Machinery	53,852	55,879	53,141	51,037
Construction In Progress	174,609	65,638	33,153	25,884

Source: S&P Capital IQ. Standard template. Financial Sources.